@entity786 , adriamycin, DTIC and @entity1891 with XXXX in the treatment of @entity242 .

@entity1 @entity1665 @entity137 @entity3136 @entity242 @entity41 @entity8442 @entity786 @entity21665 @entity1897 @entity1891 @entity1431 @entity1499 @entity204 @entity221 @entity1209
Twenty-eight consecutive adult @entity1 with locally advanced (inoperable) or metastatic soft tissue @entity242 were treated with a chemotherapy regimen (CADOM) including @entity786 , ADR, and DTIC on Day 1 of each course, and @entity1891 with intermediate-dose @entity1499 (200 mg/m2) on Day 15 followed by leucovorin rescue. Twenty-four of the @entity1 were evaluable for response and @entity137 . Three (13%) achieved a CR after chemotherapy and 6 (25%) a PR. Two of the PRs were converted to CR after surgical @entity41 . All five @entity1 achieving a CR are alive 12 to 30 months after beginning chemotherapy. Median survival of @entity1 achieving a PR was 18 months and of @entity1 achieving an MR was 7 months. Three of five @entity1 with @entity242 arising from the female genitalia achieved a CR. No treatment-related @entity204 occurred. There were five instances of @entity1431 and @entity221 . @entity1209 , and @entity1665 were common. @entity3136 , @entity21665 , @entity8442 , and @entity1897 were occasionally observed. The addition of @entity1499 did not improve the response rate when compared with our previous CYV ADIC protocol.
